Jan 31, 2014 - Does albuminuria predict renal risk and/or cardiovascular risk in obese type 2 diabetic patients? Yassamine Bentata1, Redouane Abouqal2,3.
Am J Cardiovasc Dis 2014;4(1):26-30 www.AJCD.us /ISSN:2160-200X/AJCD1311002
Brief Communication Does albuminuria predict renal risk and/or cardiovascular risk in obese type 2 diabetic patients? Yassamine Bentata1, Redouane Abouqal2,3 Department of Nephrology, Medical School of Oujda, University Mohammed First, Oujda, Morocco; 2Department of Medical Emergency, Ibn Sina University Hospital, 10000, Rabat, Morocco; 3Laboratory of Biostatistics, Clinical and Epidemiological Research, Medical School University Mohamed V Souissi, 10000, Rabat, Morocco 1
Received November 8, 2013; Accepted November 23, 2013; Epub January 15, 2014; Published January 31, 2014 Abstract: Increased urinary albumin excretion (UAE) is a marker of renal and cardiovascular risk in patients with type 2 diabetes (DT2). What about the obese patient with DT2? Does albuminuria predict the progression of renal disease and/or cardiovascular disease? The objective of this study is to determine the link between albuminuria, renal risk and cardiovascular risk in a cohort of obese DT2 patients. This is a prospective study begun in September 2006. It included DT2 patients presenting obesity defined by a body mass index (BMI)>30 Kg/m2. Three groups of patients were defined: normo-albuminuria (Urinary Albumin Excretion UAE300 mg/g). Data on 144 obese DT2 patients were compiled: The mean age of our patients was 59 ± 9 years and the sex ratio 0.26. The incidence of ESRD was higher in the macro-albuminuria group than in the two other groups (26.5% vs. 1.2%, p
